生物
先天性淋巴细胞
免疫学
细胞因子
间质细胞
白细胞介素22
免疫系统
胰腺
病理
医学
白细胞介素
先天免疫系统
癌症研究
内分泌学
作者
Jarrod A. Dudakov,Alan M. Hanash,Marcel R.M. van den Brink
标识
DOI:10.1146/annurev-immunol-032414-112123
摘要
Interleukin-22 (IL-22) is a recently described IL-10 family cytokine that is produced by T helper (Th) 17 cells, γδ T cells, NKT cells, and newly described innate lymphoid cells (ILCs). Knowledge of IL-22 biology has evolved rapidly since its discovery in 2000, and a role for IL-22 has been identified in numerous tissues, including the intestines, lung, liver, kidney, thymus, pancreas, and skin. IL-22 primarily targets nonhematopoietic epithelial and stromal cells, where it can promote proliferation and play a role in tissue regeneration. In addition, IL-22 regulates host defense at barrier surfaces. However, IL-22 has also been linked to several conditions involving inflammatory tissue pathology. In this review, we assess the current understanding of this cytokine, including its physiologic and pathologic effects on epithelial cell function.
科研通智能强力驱动
Strongly Powered by AbleSci AI